impact factor
logo
 

Full Papers

 

Untargeted lipidomics reveals specific lipid abnormalities in systemic lupus erythematosus


1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18

 

  1. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu; and School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  2. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  3. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  4. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  5. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  6. College of Pharmacy, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  7. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  8. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu; and School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  9. College of Pharmacy, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  10. College of Pharmacy, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  11. College of Pharmacy, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  12. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  13. Xuzhou Medical University, Xuzhou, Jiangsu, China.
  14. Xuzhou Medical University, Xuzhou, Jiangsu, China.
  15. Xuzhou Medical University, Xuzhou, Jiangsu, China.
  16. Xuzhou Medical University, Xuzhou, Jiangsu, China.
  17. College of Pharmacy, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  18. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. liushijia_2019@126.com

CER14672
Full Papers

purchase article

PMID: 34251324 [PubMed]

Received: 29/03/2021
Accepted : 24/05/2021
In Press: 26/06/2021

Abstract

OBJECTIVES:
To identify potential lipid biomarkers by studying changes in the blood lipid profile of patients with systemic lupus erythematosus (SLE) using lipidomics.
METHODS:
Serum samples were collected from 115 SLE patients and 115 age- and sex-matched healthy controls (HCs). Lipid profiles were assessed using ultrahigh-performance liquid chromatography coupled with Q Exactive spectrometry, and possible lipid biomarkers were screened and evaluated by univariate and multivariate analyses.
RESULTS:
Metabolic phenotypes related to SLE disease activity index (SLEDAI) scores were detected in the serum of SLE patients, and these phenotypes indicated the activity of the disease. Alterations in energy metabolism, fatty acid metabolism and other pathways were observed in patients with SLE. Phosphatidylethanolamine (16:0/18:2), lysophosphatidylethanolamine (18:0), and acylcarnitine (11:0) can be used as biomarkers for the clinical diagnosis of SLE, and receiver operating characteristic (ROC) analysis indicated their effectiveness in diagnosing this disease.
CONCLUSIONS:
Our study identified serum biomarkers related to disease activity in patients with SLE, providing a basis for its clinical diagnosis.

Rheumatology Article

Rheumatology Addendum